[{"AccountsPayableCurrent_0_Q3_USD":4176707.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":153218758.0,"PrepaidExpenseCurrent_0_Q3_USD":258198.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsOfFinancingCosts_3_Q3_USD":5533473.0,"OperatingExpenses_3_Q3_USD":29749416.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1868408.0,"OperatingExpenses_1_Q3_USD":11398655.0,"NonoperatingIncomeExpense_1_Q3_USD":1257514.0,"NetIncomeLoss_3_Q3_USD":-26190428.0,"NetIncomeLoss_1_Q3_USD":-10180141.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-22709166.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":151020193.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":166419501.0,"NonoperatingIncomeExpense_3_Q3_USD":3684257.0,"ProceedsFromWarrantExercises_3_Q3_USD":1466500.0,"ProfitLoss_1_Q3_USD":-10180141.0,"ProfitLoss_3_Q3_USD":-26190428.0,"StockIssuedDuringPeriodValueOther_3_Q3_USD":76670025.0,"StockIssuedDuringPeriodValueOther_1_Q3_USD":39981481.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":24111198.0,"StockholdersEquity_0_Q3_USD":157145729.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":210000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0071,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.9587,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":5079395.0,"ShareBasedCompensation_1_Q3_USD":2293925.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-185867658.0,"ResearchAndDevelopmentExpense_3_Q3_USD":23610888.0,"ResearchAndDevelopmentExpense_1_Q3_USD":8964528.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_3_Q3_USD":3593856.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_1_Q3_USD":1363661.0,"Liabilities_0_Q3_USD":9273772.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":869606.0,"LeaseAndRentalExpense_3_Q3_USD":117284.0,"InterestIncomeExpenseNet_3_Q3_USD":19110.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":125269.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":39000.0,"CommonStockSharesOutstanding_0_Q3_shares":75149833.0,"CommonStockSharesIssued_0_Q3_shares":75149833.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeCurrent_0_Q3_USD":443831.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":128311027.0,"Assets_0_Q3_USD":166419501.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11059202.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":5079395.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2293925.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":342938236.0,"AccruedLiabilitiesCurrent_0_Q3_USD":4653234.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":157560045.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.14,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.39,"EmployeeBenefitsAndShareBasedCompensation_1_Q3_USD":2293925.0,"InterestIncomeExpenseNet_1_Q3_USD":11453.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-185641.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":3751918.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":443831.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":1336660.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":187653.0,"IncomeTaxesReceivable_0_Q3_USD":8601258.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-26065159.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-10141141.0,"GeneralAndAdministrativeExpense_3_Q3_USD":6138528.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2434127.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":17191.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-160880.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":6664000.0,"EmployeeBenefitsAndShareBasedCompensation_3_Q3_USD":5079395.0,"LeaseAndRentalExpense_1_Q3_USD":18994.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":1868408.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]